For the third fiscal quarter ended June 30, 2026, Outlook Therapeutics reported net loss attributable to common stockholders of $20.3 million, or $0.15 per basic and diluted share. This compares with ...
Landmark FDA Approval Is an Important Milestone in Retina Care, Bringing Patients and Physicians an Ophthalmic Bevacizumab Developed Specifically ...
Landmark FDA Approval Is an Important Milestone in Retina Care, Bringing Patients and Physicians an Ophthalmic Bevacizumab Developed Specifically for the Eye Following Years of Rigorous Clinical and ...
Peptide injections have become one of the biggest wellness trends in recent times. Celebrities, influencers, and social media users claim that these injections can improve muscle growth, speed up ...
Originally designed to tackle diabetes, weight loss injections such as Wegovy and Mounjaro are now being taken by 2.4 million Brits. While the drugs, which mimic a hormone called glucagon-like peptide ...
Outfitting cells in "invisibility cloaks" may offer an easier, less damaging treatment pathway for people with diabetes ...
The FDA has cleared an IND for RAG-1C, a first-in-class saRNA therapy targeting proliferative vitreoretinopathy.
Staying on therapy results in better visual outcomes. One implication is that if we have newer drugs that last as long as 180 ...
Babies aren’t born with enough vitamin K, which is essential to clot blood. This is why it’s recommended in Australia that all newborns receive a vitamin K injection at birth. Without it, they’re at ...
Semaglutide is a drug used for type 2 diabetes, weight loss, and more. Oral tablets and injections are both effective ways to take semaglutide. Oral tablets do not require the use of needles, but you ...
Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results